肝病患者AFu ADA和CHE联合检测的临床价值  

Clinical Significane of Combined AFu,ADA and CHE Detection for Patients with Liver Diseases

作　　者：聂翠华 杜梦欣 

机构地区：[1]常德市皮肤病医院,湖南常德415000

出　　处：《实用医技杂志》2008年第5期562-563,共2页Journal of Practical Medical Techniques

摘　　要：目的:探讨联合检测a-L-岩藻糖苷酶(AFu)、腺苷脱氨酶(ADA)、胆碱酯酶(CHE)对肝病诊断的临床价值。方法:应用日立7080全自动生化分析仪对肝病患者135例,健康对照组92例血清AFu、ADA、CHE水平进行联合检测。结果:实验组血清AFu、ADA水平明显高于正常人组(P<0.01),CHE水平实验组明显低于正常对照组。AFu在肝癌组阳性率为79.2%,ADA、CHE在肝硬化组阳性率高于90%。结论:肝癌时,AFu应用价值较高;肝硬化时,ADA和CHE应用价值较高,联合检测AFu、ADA、CHE水平在一定程度上能反映肝脏的功能,对于肝病的诊断,临床疗效及预后判断具有一定参考价值。Objective To investigate clinical value of combined Serum alpha-L-fucosidase(AFu),adenosine deaminase(ADA)and Cholinesterase(CHE)detection for the diagnosis of liver diseases.Methods AFu,ADA and CHE in the serum were studied in 135 patients with liver diseases and 92 healthy individuals by HITACHI 7080.Results The serum AFu,ADA levels were significantly higher in the patients than those in controls(P<0.01),CHE of the experiment group was obviously increases nearly 80%cases of PHC,the positive rates of AD...

关 键 词：肝病a-L-岩藻糖苷酶 腺苷脱氨酶 胆碱酯酶 

分 类 号：R575[医药卫生—消化系统]